GLP-3 30mg

Product Details

Retatrutide (GLP-3 Tri-Agonist) is a synthetic investigational peptide designed to simultaneously activate GLP-1, GIP, and glucagon receptors, providing a unique multi-pathway model for studying complex metabolic regulation. In experimental systems, Retatrutide is used to investigate energy balance, glucose control mechanisms, lipid mobilization, and integrated endocrine signaling arising from combined incretin and glucagon receptor engagement. Its tri-agonist profile allows researchers to explore receptor crosstalk, metabolic synergy, and coordinated hormonal responses in ways that single- or dual-agonists cannot replicate. This broad activity spectrum makes Retatrutide a valuable tool for preclinical studies focused on next-generation metabolic pathway modulation.

For laboratory and in-vitro research only. Not for human consumption. COAs available on request.